Advances in Checkpoints Immunology from Autoimmunity to Oncology to Infectious Diseases
joint with Cancer Neoantigens, Vaccines and Viruses
Scientific Organizers: David M. Lee, Arlene H. Sharpe and William H. Robinson
Date: February 06 - 10, 2022
|InPerson Location: Fairmont Banff Springs, Banff, AB, Canada|
|Meeting is available to view On Demand, click register button below for more details|
For Updated Health and Safety Guidelines for Keystone Symposia in-person meetings, click here
Understanding of the mechanisms by which checkpoints regulate immune responses is burgeoning; molecular insights into checkpoint signaling, and complexities regarding degrees of checkpoint regulation in immune exhaustion vs. immune homeostasis are coming to light. The use of checkpoint antagonist therapeutics in Oncology has ushered in a transformation for treatment and led to major leaps in our understanding of checkpoint functions, both in health and in the context of immune responses to tumors. There are also rapidly emerging insights into the role of checkpoints in immune dysfunction seen in Autoimmune diseases, and checkpoint-targeted therapies for Autoimmune diseases are now in clinical studies. Further, treatment-associated autoimmunity syndromes comprise an important adverse event for cancer immunotherapy. While these syndromes are currently poorly understood, their analysis promises to shed new insights into improving tolerability of cancer treatment as well as into immune dysfunction in Autoimmune diseases. The meeting will provide a forum for cross-fertilization across disciplines, with a particular focus on Autoimmunity and will also include opportunities that stimulate new directions for investigation in Oncology and other diseases.
Scholarship Deadline: October 21 2021 details
Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies
Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.
IT'S NOT TOO LATE TO SUBMIT YOUR ABSTRACT. Abstracts received may still be considered for a short talk if space is available. We will accept abstracts for poster acceptance until 2 weeks prior to the meeting start date.
We gratefully acknowledge additional support from these exhibitors at this conference: